Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G de Groot

Showing results (91-100 of 275) with videos related to

Pageof 28
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpuraE Groot, J J J Hulstein, C N Rison, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2007
Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosisK S Steen, M J Peters, S Zweegman, et al.
Human Genetics|January 1, 1981
Characterization of a complex Philadelphia translocation (1p-;9q+;22q-) by gene mappingA H Geurts van Kessel, A J van Agthoven, P G de Groot, et al.
Circulation|September 1, 1993
Both increased and decreased platelet adhesion to thermally injured subendothelium is caused by denaturation of von Willebrand factorA N Bos, M J Post, P G de Groot, et al.
Thrombosis Research|February 15, 1987
Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjectsR Kallmann, H K Nieuwenhuis, P G de Groot, et al.
Annals of the Rheumatic Diseases|May 1, 1988
Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patientsR H Derksen, P Hasselaar, L Blokzijl, et al.
Blood|July 15, 1990
Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole bloodR R Hantgan, G Hindriks, R G Taylor, et al.
Annals of the Rheumatic Diseases|December 1, 1989
Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective studyH J Out, P G de Groot, P Hasselaar, et al.
Blood|May 1, 1988
High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterizationF van Iwaarden, P G de Groot, J J Sixma, et al.
Thrombosis and Haemostasis|December 1, 1996
Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodiesD A Horbach, E van Oort, R C Donders, et al.
Pageof 28

Showing results (91-100 of 275) with videos related to

Sort By:
Pageof 28
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpuraE Groot, J J J Hulstein, C N Rison, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2007
Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosisK S Steen, M J Peters, S Zweegman, et al.
Human Genetics|January 1, 1981
Characterization of a complex Philadelphia translocation (1p-;9q+;22q-) by gene mappingA H Geurts van Kessel, A J van Agthoven, P G de Groot, et al.
Circulation|September 1, 1993
Both increased and decreased platelet adhesion to thermally injured subendothelium is caused by denaturation of von Willebrand factorA N Bos, M J Post, P G de Groot, et al.
Thrombosis Research|February 15, 1987
Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjectsR Kallmann, H K Nieuwenhuis, P G de Groot, et al.
Annals of the Rheumatic Diseases|May 1, 1988
Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patientsR H Derksen, P Hasselaar, L Blokzijl, et al.
Blood|July 15, 1990
Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole bloodR R Hantgan, G Hindriks, R G Taylor, et al.
Annals of the Rheumatic Diseases|December 1, 1989
Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective studyH J Out, P G de Groot, P Hasselaar, et al.
Blood|May 1, 1988
High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterizationF van Iwaarden, P G de Groot, J J Sixma, et al.
Thrombosis and Haemostasis|December 1, 1996
Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodiesD A Horbach, E van Oort, R C Donders, et al.
Pageof 28